BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10690525)

  • 1. Serum total and free prostate-specific antigen for breast cancer diagnosis in women.
    Black MH; Giai M; Ponzone R; Sismondi P; Yu H; Diamandis EP
    Clin Cancer Res; 2000 Feb; 6(2):467-73. PubMed ID: 10690525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
    Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I
    Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer.
    Hautmann S; Huland E; Grupp C; Haese A; Huland H
    Anticancer Res; 2000; 20(3B):2151-4. PubMed ID: 10928169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen in the serum of women with benign breast disease.
    Radowicki S; Kunicki M; Bandurska-Stankiewicz E
    Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):212-6. PubMed ID: 17850950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.
    Stenman UH; Leinonen J; Alfthan H; Rannikko S; Tuhkanen K; Alfthan O
    Cancer Res; 1991 Jan; 51(1):222-6. PubMed ID: 1703033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease.
    Mikolajczyk SD; Rittenhouse HG
    Rinsho Byori; 2004 Mar; 52(3):223-30. PubMed ID: 15137320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis.
    Sarrats A; Comet J; Tabarés G; Ramírez M; Aleixandre RN; de Llorens R; Peracaula R
    Prostate; 2010 Jan; 70(1):1-9. PubMed ID: 19670261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer.
    Finne P; Zhang WM; Auvinen A; Leinonen J; Määttänen L; Rannikko S; Tammela TL; Stenman UH
    J Urol; 2000 Dec; 164(6):1956-60. PubMed ID: 11061890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen detection by ultrasensitive assay in samples from women.
    Filella X; Molina R; Alcover J; Menéndez V; Giménez N; Jo J; Carretero P; Ballesta AM
    Prostate; 1996 Nov; 29(5):311-6. PubMed ID: 8899004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen (PSA) complexed to alpha1-antichymotrypsin improves prostate cancer detection using total PSA in Japanese patients with total PSA levels of 2.0-4.0 ng/mL.
    Kobayashi T; Kamoto T; Nishizawa K; Mitsumori K; Ogura K; Ide Y
    BJU Int; 2005 Apr; 95(6):761-5. PubMed ID: 15794778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free to complexed PSA ratio in differentiating benign prostate hyperplasia from prostate cancer.
    Filella X; Alcover J; Corral JM; Molina R; Beardo P; Ballesta AM
    Anticancer Res; 2001; 21(5):3717-20. PubMed ID: 11848550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer.
    Lilja H
    Scand J Clin Lab Invest Suppl; 1995; 220():47-56. PubMed ID: 7544478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A; Dworschack RT; Partin AW
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The percentage of free prostate specific antigen used in detecting prostate cancer].
    Yang L; Fang Z; Song J; Deng S
    Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):47-9. PubMed ID: 11829778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of prostate cancer and benign prostate hyperplasia using two-dimensional electrophoresis.
    Charrier JP; Tournel C; Michel S; Comby S; Jolivet-Reynaud C; Passagot J; Dalbon P; Chautard D; Jolivet M
    Electrophoresis; 2001 May; 22(9):1861-6. PubMed ID: 11425243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
    Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
    Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
    Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
    J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concentrations of free form and complex form of prostate-specific antigen in serum of alpha 2 macroglobulin deficient patients with prostatic carcinoma].
    Kanoh Y; Jimbo S; Shibuya M; Matsuyama N; Mashiko T; Tanaka T; Egawa S; Ohtani H
    Rinsho Byori; 1998 Sep; 46(9):923-9. PubMed ID: 9800478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer.
    Stephan C; Jung K; Lein M; Sinha P; Schnorr D; Loening SA
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1133-47. PubMed ID: 11097220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.
    Brawer MK; Cheli CD; Neaman IE; Goldblatt J; Smith C; Schwartz MK; Bruzek DJ; Morris DL; Sokoll LJ; Chan DW; Yeung KK; Partin AW; Allard WJ
    J Urol; 2000 May; 163(5):1476-80. PubMed ID: 10751861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.